AMEX: BTX       Brooklyn Immunotherapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
0.75   -0.09 (10.71%)  0.74 - 0.83  396,400


Avg Volume (4 weeks):618,512
4 Weeks Range:0.70 - 1.44
4 Weeks Price Volatility (%):
52 Weeks Range:0.70 - 23.34
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

BioTime Inc is a clinical-stage biotechnology company. Its objective is the development and commercialization of novel therapies developed with the help of the company's core technology platforms. The core therapeutic technologies are based on pluripotent stem cells that can become any of the cell types in the human body. Pluripotent stem cells have potential applications in many areas of medicine, including several age-related degenerative diseases and conditions for which there presently are no cures. The product portfolio includes Renevia, a potential treatment for HIV-related facial lipoatrophy; AST-VAC1, a cancer immunotherapy; and OpRegen, a potential therapy derived from pluripotent stem cells to treat the dry form of age-related macular degeneration.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2267  7854  985  1061 

Top 10 Active Counters
 TQQQ 28.15-4.81 
 AMD 96.28-6.19 
 SQQQ 57.21+7.26 
 NU 3.82-0.26 
 SPY 391.86-16.46 
 AAPL 140.82-8.42 
 BRQS 0.191+0.017 
 SNDL 0.413-0.024 
 UVXY 17.65+3.13 
 GNUS 0.775+0.088